Literature DB >> 2180511

Involvement of tobacco in alcoholism and illicit drug use.

J E Henningfield1, R Clayton, W Pollin.   

Abstract

Survey data from the United States indicate that tobacco use is associated with the initiation of use of other addicting substances, and that increasing levels of tobacco use are associated with increasing levels of use of other psychoactive substances. Furthermore, factors affecting initiation, abstinence, and relapse to the use of tobacco, alcohol, and opioids are similar in nature. In addition, there are similarities in the addictive process underlying the use of these substances. Taken together, these data suggest that tobacco use is involved, possibly more than by simple association, in the use of other substances containing psychoactive chemicals. In the present paper we discuss the involvement of tobacco in the use of alcohol, opioids, cocaine, and other substances, as well as some of the implications of these observations for researchers and clinicians. One such implication is that it may be possible to use tobacco and nicotine as models for phenomena of interest to other substance use researchers. For example, drug abuse treatment and prevention strategies could be explored using tobacco use as a target behavior, and biological phenomena such as the development of tolerance and physical dependence may be more readily studied with nicotine than with many other drugs. Certain pharmacologic differences across substances are also discussed in light of their implications for development of treatment and drug control policies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180511     DOI: 10.1111/j.1360-0443.1990.tb03084.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


  39 in total

1.  Associations of family environment and individual factors with tobacco, alcohol, and illicit drug use in adolescents.

Authors:  B Challier; N Chau; R Prédine; M Choquet; B Legras
Journal:  Eur J Epidemiol       Date:  2000-01       Impact factor: 8.082

2.  Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress?

Authors:  J E Henningfield; K O Fagerstrom
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

3.  Psychostimulant dependence in a community sample.

Authors:  Li-Tzy Wu; William E Schlenger
Journal:  Subst Use Misuse       Date:  2003-01       Impact factor: 2.164

Review 4.  Smoking, physical activity, and diet in North American youth: where are we at?

Authors:  Jennifer L O'Loughlin; Jill Tarasuk
Journal:  Can J Public Health       Date:  2003 Jan-Feb

Review 5.  Nicotine dependence: a preventable risk factor for other diseases.

Authors:  C Cohen; J E Henningfield
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

Review 6.  Regulatory strategies to reduce tobacco addiction in youth.

Authors:  J E Henningfield; E T Moolchan; M Zeller
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

7.  Health conditions among aging narcotics addicts: medical examination results.

Authors:  Yih-Ing Hser; Lillian Gelberg; Valerie Hoffman; Christine E Grella; William McCarthy; M Douglas Anglin
Journal:  J Behav Med       Date:  2004-12

Review 8.  Translational neuroimaging: positron emission tomography studies of monoamine oxidase.

Authors:  Joanna S Fowler; Jean Logan; Nora D Volkow; Gene-Jack Wang
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

9.  The reinforcement enhancing effects of nicotine depend on the incentive value of non-drug reinforcers and increase with repeated drug injections.

Authors:  Matthew I Palmatier; Gina L Matteson; Jessica J Black; Xiu Liu; Anthony R Caggiula; Laure Craven; Eric C Donny; Alan F Sved
Journal:  Drug Alcohol Depend       Date:  2007-01-19       Impact factor: 4.492

10.  Low monoamine oxidase B in peripheral organs in smokers.

Authors:  Joanna S Fowler; Jean Logan; Gene-Jack Wang; Nora D Volkow; Frank Telang; Wei Zhu; Dinko Franceschi; Naomi Pappas; Richard Ferrieri; Colleen Shea; Victor Garza; Youwen Xu; David Schlyer; S John Gatley; Yu-Shin Ding; David Alexoff; Donald Warner; Noelwah Netusil; Pauline Carter; Millard Jayne; Payton King; Paul Vaska
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.